A Bull/Bear Outline for the Unilife Debate

2:19:21 PM EDT, Thursday, December 5, 2013 · Brian L. Wilson / Bio-Wire

In our previous article (link) on Unilife (NASDAQ: UNIS), published on November 27th 2013, we predicted that UNIS would probably break 100% in YTD gains. After the company announced on ...

Tickers Mentioned:

OPKO: Expecting More Strength in 2014 on Pipeline Developments

2:34:28 PM EDT, Friday, November 22, 2013 · Brian L. Wilson / Bio-Wire

It hasn’t been a good year for short sellers betting against the rapidly growing healthcare conglomerate OPKO Health (NYSE: OPK) and its CEO/Chairman – Dr. Phillip Frost. Since the start of the ...

Tickers Mentioned:

Ohr Pharma: A Pure 2014 Catalyst Play With Large Potential

1:36:10 PM EDT, Tuesday, November 12, 2013 · Brian L. Wilson / Bio-Wire

One of the biotechs of 2013 that continues to hold its ground is Ohr Pharmaceutical (NASDAQ: OHRP) – a company that is best known for its Squalamine eye drops which ...

Tickers Mentioned:

An Overview of Horizon Pharma After Q3 Earnings

1:35:41 PM EDT, Tuesday, November 12, 2013 · Brian L. Wilson / Bio-Wire

Recently, Horizon Pharma (HZNP) has been quite an interesting play in the biotech space. Speculation on the bullish side has been dominating (as demonstrated with the 95% rally the stock ...

Tickers Mentioned:

Categorizing Biology Investments, and 2 Niche Market Stock Picks

9:03:38 PM EDT, Tuesday, October 29, 2013 · Brian L. Wilson / Bio-Wire

Note: In addition to my regular discussion on select companies in the life science (“applied biology”) space, I’ve included a top-down discussion and exemplification of my main categorization method. For ...

Tickers Mentioned: , ,